Pomalidomide and Subdural haematoma - a phase IV clinical study of FDA data

Summary:

Subdural haematoma is reported as a side effect among people who take Pomalidomide (pomalidomide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Clopidogrel, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Subdural haematoma when taking Pomalidomide. It is created by eHealthMe based on reports of 14,524 people who have side effects when taking Pomalidomide from the FDA, and is updated regularly.

What is Pomalidomide?

Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.

What is Subdural haematoma?

Subdural haematoma (blood collects between the skull and the surface of the brain) is found to be associated with 998 drugs and 1,084 conditions by eHealthMe. Check the latest studies of Subdural haematoma.

On Jul, 26, 2026

14,524 people reported to have side effects when taking Pomalidomide.
Among them, 23 people (0.16%) have Subdural haematoma.

Could Pomalidomide cause Subdural haematoma?

Among these 23 people:

How long have people been on Pomalidomide when they have Subdural haematoma? *

What is the gender of people who have Subdural haematoma when taking Pomalidomide? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Subdural haematoma when taking Pomalidomide? *

What are other drugs people take besides Pomalidomide? *

What are other side effects people have besides Subdural haematoma? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 43.48%
Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 10 people, 43.48%
Multiple Myeloma (cancer of the plasma cells): 10 people, 43.48%
Fall: 6 people, 26.09%
Disease Progression: 5 people, 21.74%
Paraproteinaemia (normal or abnormal plasma protein appearing in large quantities): 5 people, 21.74%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 4 people, 17.39%
Fever: 4 people, 17.39%
Haemoglobin Decreased: 3 people, 13.04%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 13.04%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 20 people, 86.96%
Amyloidosis (a tumour within which amyloid is produced): 3 people, 13.04%
Headache (pain in head): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Pomalidomide and have Subdural haematoma?

- Check whether Subdural haematoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pomalidomide:

Pomalidomide (14,524 reports)

Browse all side effects of Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Subdural haematoma:

Subdural haematoma (998 drugs)

Browse all the conditions that are associated with Subdural haematoma:

Subdural haematoma (1,084 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pomalidomide (the active ingredients of Pomalidomide) and Pomalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.